HIGH-DOSE HIGH-FREQUENCY AFLIBERCEPT FOR RECALCITRANT NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

PURPOSE: To determine the efficacy of monthly (0.1 mL/4 mg) aflibercept for refractory neovascular age-related macular degeneration (wet age-related macular degeneration). METHODS: This was a retrospective interventional case series in which patients with wet age-related macular degeneration were tr...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Qi Sheng, Gaber, Raouf, Meshi, Amit, Ramkumar, Hema L., Alam, Mostafa, Muftuoglu, Ilkay Kilic, Freeman, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2018
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726954/
https://www.ncbi.nlm.nih.gov/pubmed/28604541
http://dx.doi.org/10.1097/IAE.0000000000001726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726954/
https://www.ncbi.nlm.nih.gov/pubmed/28604541
http://dx.doi.org/10.1097/IAE.0000000000001726

Ejemplares similares